RAPID3 (Routine Assessment of Patient Index Data 3), a Rheumatoid Arthritis Index Without Formal Joint Counts for Routine Care: Proposed Severity Categories Compared to Disease Activity Score and Clinical Disease Activity Index Categories

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Rheumatology

• Publication date

  2008-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3899/jrheum.080182PMID 18793006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Disease Activity Score and the EULAR response criteria.

  2009cited by this paper
• Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.

  2008cited by this paper
• Comparison of Treatment Strategies in Early Rheumatoid Arthritis: A Randomized Trial

  2008cited by this paper
• Visual analog scales in formats other than a 10 centimeter horizontal line to assess pain and other clinical data.

  2008cited by this paper
• Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials.

  2008cited by this paper
• An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures.

  2007cited by this paper
• Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations.

  2007cited by this paper
• Comparison of Treatment Strategies in Early Rheumatoid Arthritis

  2007cited by this paper
• Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)

  2007cited by this paper
• Quantitative measurement of patient status in the regular care of patients with rheumatic diseases over 25 years as a continuous quality improvement activity, rather than traditional research.

  2007cited by this paper
• QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries

  2007cited by this paper
• Remission of rheumatoid arthritis: should we care about definitions?

  2006cited by this paper
• The DAS is the most specific measure, but a patient questionnaire is the most informative measure to assess rheumatoid arthritis.

  2006cited by this paper
• Quantitative measures to assess patients with rheumatic diseases: 2006 update.

  2006cited by this paper
• An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis.

  2006cited by this paper
• DAS remission cut points.

  2006cited by this paper
• A 3-page standard protocol to evaluate rheumatoid arthritis (SPERA): efficient capture of essential data for clinical trials and observational studies.

  2005cited by this paper
• Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.

  2005cited by this paper
• Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count

  2005cited by this paper
• The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis.

  2005cited by this paper
• Depression in Primary Care: Learning Lessons in a National Quality Improvement Program

  2005cited by this paper
• The Disease Activity Score and the EULAR response criteria.

  2005cited by this paper
• Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

  2005cited by this paper
• Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind?

  2005cited by this paper
• A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II).

  2005cited by this paper
• Further Development of a Physical Function Scale on a Multidimensional Health Assessment Questionnaire for Standard Care of Patients with Rheumatic Diseases ASSESSMENT VALIDITY RELIABILITY RHEUMATOID ARTHRITIS ACTIVITIES OF DAILY LIVING

  2005cited by this paper
• Performance of health status measures with a pen based personal digital assistant

  2005cited by this paper
• Further development of a physical function scale on a MDHAQ [corrected] for standard care of patients with rheumatic diseases.

  2005cited by this paper
• Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.

  2005cited by this paper
• Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.

  2004cited by this paper
• The assessment of rheumatoid arthritis and the acceptability of self-report questionnaires in clinical practice.

  2003cited by this paper
• The role of ultrasonography and magnetic resonance imaging in early rheumatoid arthritis.

  2003cited by this paper
• An infrastructure of patient questionnaires at each rheumatology visit: improving efficiency and documenting care.

  2000cited by this paper
• Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled t

  2000cited by this paper
• Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.

  1999cited by this paper
• Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format.

  1999cited by this paper
• Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years.

  1997cited by this paper
• Standardising joint assessment in rheumatoid arthritis

  1996cited by this paper
• American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

  1995cited by this paper
• A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity.

  1995cited by this paper
• Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

  1995cited by this paper
• The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

  1993cited by this paper
• The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials

  1993cited by this paper
• Development of a disease activity score based on judgment in clinical practice by rheumatologists.

  1993cited by this paper
• OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction.

  1993cited by this paper
• The rapid assessment of disease activity in rheumatology (radar) questionnaire. Validity and sensitivity to change of a patient self-report measure of joint count and clinical status.

  1992cited by this paper
• Comparison of four articular indices for use in clinical trials in rheumatoid arthritis: patient, order and observer variation.

  1991cited by this paper
• Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

  1990cited by this paper
• A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis.

  1989cited by this paper
• Significant changes in Ritchie scores.

  1988cited by this paper
• An experiment in reducing interobserver variability of the examination for joint tenderness.

  1988cited by this paper
• Grading of tenderness as a source of interrater error in the Ritchie articular index.

  1985cited by this paper
• Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire.

  1983cited by this paper
• Measurement of patient outcome in arthritis.

  1980cited by this paper

• Patient Preferences for Treatments of Rheumatoid Arthritis: A Discrete Choice Experiment Evaluating Preference for Novel Neuroimmune Modulation Devices

  2026cites this paper
• Similar Pain Scores in Rheumatoid Arthritis and Osteoarthritis Over 45 Years Despite Dramatically Fewer Swollen Joints in Rheumatoid Arthritis: Are Scores Based as Much on Pain Sensitization and Patient Distress as on Inflammation and/or Structural Damage?

  2026cites this paper
• Ecological momentary assessment of daily patient-reported outcomes and actigraphy-measured physical activity and sleep in patients with rheumatoid arthritis and spondyloarthritis: a study protocol

  2026cites this paper
• Rheumatoid arthritis in crisis: investigating the impact of stress on RA flares during the COVID-19 pandemic

  2026cites this paper
• Medical gaslighting in rheumatology: listening, learning, and leading.

  2025cites this paper
• Exploring the immunomodulatory effects of environmental contaminants on autoimmune patients: An in vitro approach

  2025cites this paper
• RheuMetric Physician 0 to 10 Estimates of Inflammation, Damage, and Patient Distress at Initial Versus Follow‐Up Visits in Contemporary Rheumatology Care

  2025cites this paper
• Improving early referrals for inflammatory arthritis through primary care engagement: a quality improvement initiative

  2025cites this paper
• Promise of rheumatoid arthritis therapy: From clinical deep remission to drug-free.

  2025cites this paper
• Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis

  2025cites this paper
• Adding the patient perspective: the necessity of patient reported outcomes in cardiac surgery clinical trials.

  2025cites this paper
• Should Joint Deformity, which is More Common Than Swelling or Tenderness, be Assessed in all Rheumatoid Arthritis Patients and Databases?

  2025cites this paper
• Axial spondyloarthritis treatment patterns, clinical characteristics and patient-reported outcome collection in US rheumatology practices

  2025cites this paper
• Meteorosensitivity of patients with rheumatic musculoskeletal diseases

  2025cites this paper
• Comparison of the Multidimensional Health Assessment Questionnaire (MDHAQ-RAPID3) with the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional Index (BASFI) in Patients with Ankylosing Spondylitis

  2025cites this paper
• Predictors of adherence to a digital health application in patients with inflammatory arthritis: retrospective analysis

  2025cites this paper
• Assessing Rheumatoid Arthritis Disease Activity Measures in Ethnic Minority Patients in the United States: Real-World Data From the Ethnic Minority Rheumatoid Arthritis Consortium Registry.

  2025cites this paper
• Where we Live matters: Varied Disease Burden and Treatment Patterns in Psoriatic Arthritis in the United States.

  2025cites this paper
• Global ultrasound synovitis scores reflect symptom severity and patient outcomes in chronic chikungunya disease.

  2025cites this paper
• Elevated DAS28, CDAI, RAPID3 and five of seven RA core data set measures in patients with positive screens for anxiety, depression or fibromyalgia on an MDHAQ

  2025cites this paper
• PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA) trial: a multicentre, open-label, randomised controlled trial comparing routine care with a tailor-made approach

  2025cites this paper
• PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs

  2024cites this paper
• Interrater reliability of RheuMetric checklist scales for physician global assessment, inflammation, damage and patient distress

  2024cites this paper
• Remote monitoring of rheumatoid arthritis (REMORA): study protocol for a stepped wedge cluster randomized trial and process evaluation of an integrated symptom tracking intervention

  2024cites this paper
• Patient trust, quality communication, and medication adherence in rheumatoid arthritis patients highly affected by social determinants of health.

  2024cites this paper
• Remote patient-reported outcome measure triage score for monitoring disease activity and allocation of consultations in rheumatoid arthritis patients

  2024cites this paper
• Comparison and Influence of a Multicomponent Educational Program on the Patient-Reported Outcomes of a Group of Patients With Rheumatoid Arthritis

  2024cites this paper
• Antigen-specific T cell frequency and phenotype mirrors disease activity in DRB1*04:04+ rheumatoid arthritis patients.

  2024cites this paper
• Factors associated with discrepancies in disease activity as assessed by SDAI and RAPID3 in patients with rheumatoid arthritis: Data from a multicenter observational study (T-FLAG).

  2024cites this paper
• How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice

  2024cites this paper
• Correlation analysis of outcomes assessed by patients and healthcare professionals: Exploration in adherence and education in Rheumatoid Arthritis

  2024cites this paper
• Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count

  2024cites this paper
• Can a simple 0-10 RheuMetric physician estimate of inflammatory activity (DOCINF) depict a detailed swollen joint count (SJC) as accurately as a DAS28 or CDAI in patients with rheumatoid arthritis?

  2024cites this paper
• Physician estimate of inflammation vs global assessment in explaining variations in swollen joint counts in rheumatoid arthritis patients

  2024cites this paper
• Association between laughter, frailty, and depression in rheumatoid arthritis patients

  2024cites this paper
• TEMPORARY REMOVAL: PROMIS-29 in rheumatoid arthritis patients who screen positive or negative for fibromyalgia on MDHAQ FAST4 (fibromyalgia assessment screening tool) or 2011 fibromyalgia criteria.

  2024cites this paper
• Validation and Cultural Adaptation of Persian Version of Multidimensional Health Assessment Questionnaire in Rheumatoid Arthritis Patients

  2024cites this paper
• Real‐World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First‐Line Tumor Necrosis Factor Inhibitor Therapy in the United States

  2024cites this paper
• Increased physical activity promotes skin clearance, improves cardiovascular and psychological health, and increases functional capacity in patients with psoriasis

  2024cites this paper
• Comparison of Remotely Applied and Face-to-Face Disease Activity Scores in Saudi Arabian Patients With Rheumatoid Arthritis: A Prospective Cohort Study

  2024cites this paper
• Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis

  2024influential citation
• Evaluating Factors Associated With Telehealth Appropriateness in Outpatient Rheumatoid Arthritis Encounters Using the Encounter Appropriateness Score for You (EASY)

  2024cites this paper
• Análise de correlação dos resultados avaliados por pacientes e profissionais de saúde: Exploração da adesão e educação na Artrite Reumatoide

  2024cites this paper
• On difficulties to define prognostic factors for clinical practice in rheumatoid arthritis

  2024cites this paper
• RheuMetric Quantitative 0 to 10 Physician Estimates of Inflammation, Damage, and Distress in Rheumatoid Arthritis: Validation Against Reference Measures

  2023cites this paper
• Correlation of Disease Activity Scores and Routine Assessment of Patient Index Data (RAPID3) on a Multidimensional Health Assessment Questionnaire in Patients With Rheumatoid Arthritis: A Saudi Experience

  2023cites this paper
• La artritis reumatoide

  2023cites this paper
• Integrating PROMIS Measures in a Treat-to-Target Approach to Standardize Patient-Centered Treatment of Rheumatoid Arthritis

  2023cites this paper
• Encounter Appropriateness Score for You Model: Development and Pilot Implementation of a Predictive Model to Identify Visits Appropriate for Telehealth in Rheumatology

  2023cites this paper
• The role of personality traits on self-medicated cannabis in rheumatoid arthritis patients: A multivariable analysis

  2023influential citation
• Epidemiology and clinical characteristics of interstitial lung disease in patients with rheumatoid arthritis from the JointMan database

  2023cites this paper
• Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States

  2023cites this paper
• Sleep disturbances in patients with psoriatic arthritis

  2023cites this paper
• Evaluating Provider Perceptions of Telehealth Utility in Outpatient Rheumatology Telehealth Encounters

  2023cites this paper
• Impact of Perceived Stress During the SARS-CoV-2 Pandemic on Rheumatoid Arthritis Patients' Disease Activity

  2022cites this paper
• DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study

  2022cites this paper
• DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study

  2022cites this paper
• Plasma angiotensin peptides as biomarkers of rheumatoid arthritis are correlated with anti-ACE2 auto-antibodies level and disease intensity

  2022cites this paper
• Functional and mental health affection (depression, anxiety, stress) among Egyptian rheumatic diseases patients during COVID-19 pandemic.

  2022cites this paper
• Vatari guggulu and mahaushadhi kwatha in amavata (Rheumatoid Arthritis): An open-label, single-arm clinical study

  2022cites this paper
• Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting.

  2022cites this paper
• Patient global assessment is elevated by up to 5 of 10 units in patients with inflammatory arthritis who screen positive for fibromyalgia (by FAST4) and/or depression (by MDS2) on a single MDHAQ.

  2022cites this paper
• Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis

  2022cites this paper
• Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: a systematic review following COSMIN guidelines

  2022cites this paper
• Protocol for the pilot randomized trial of the CArdiovascular Risk assEssment for Rheumatoid Arthritis (CARE RA) intervention: a peer coach behavioral intervention

  2022cites this paper
• Métricas em artrite reumatoide: uma revisão para a prática clínica

  2022cites this paper
• Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial.

  2022cites this paper
• Development of a Natural Language Processing System for Extracting Rheumatoid Arthritis Outcomes From Clinical Notes Using the National Rheumatology Informatics System for Effectiveness Registry

  2022cites this paper
• A snapshot of primary care physiotherapy management of knee osteoarthritis in an Australian setting: does it align with evidence-based guidelines?

  2022cites this paper
• Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists

  2022influential citation
• Digitally-supported patient-centered asynchronous outpatient follow-up in rheumatoid arthritis - an explorative qualitative study

  2022cites this paper
• Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry

  2022cites this paper
• Patient and Physician Global Assessments of Disease Status in Systemic Sclerosis

  2022cites this paper
• Correlation of patient‐reported routine assessment of patient index data with clinical measures of disease activity in psoriatic arthritis

  2022cites this paper
• Probability of Medication Intensifications in Rheumatoid Arthritis Patients With Low Disease Activity Scores on Their Patient-Reported Outcomes

  2022cites this paper
• The RAPID3 questionnaire as a screening tool to reduce the number of outpatient clinic visits: a retrospective cohort study

  2022cites this paper
• The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases

  2021cites this paper
• A Self-Report Multidimensional Health Assessment Questionnaire (MDHAQ) for Face-To-Face or Telemedicine Encounters to Assess Clinical Severity (RAPID3) and Screen for Fibromyalgia (FAST) and Depression (DEP)

  2021cites this paper
• Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region

  2021cites this paper
• Rheumatoid Arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measures

  2021influential citation
• Measuring Physical Function in Psoriatic Arthritis: Comparing the Multidimensional Health Assessment Questionnaire to the Health Assessment Questionnaire–Disability Index

  2021cites this paper
• Pentosan polysulfate sodium for Ross River virus-induced arthralgia: a phase 2a, randomized, double-blind, placebo-controlled study

  2021cites this paper
• Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA study.

  2021cites this paper
• Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower

  2021cites this paper
• Coupled Effect of Electronic Medical Record Modifications and Lean Six Sigma Methodology on Rheumatoid Arthritis Disease Activity Measurement and Treat‐to‐Target Outcomes

  2021cites this paper
• Association between physician–patient relationship and the use of complementary and alternative medicine in patients with rheumatoid arthritis

  2021cites this paper
• Evaluation of a medication optimization intervention and predictors of medication adherence, patient satisfaction and medication adverse events in patients with rheumatoid arthritis.

  2021cites this paper
• A Novel Qualitative Study Assessing Patient-Reported Outcome Measures Among People Living with Psoriatic Arthritis or Ankylosing Spondylitis

  2021cites this paper
• Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection

  2021cites this paper
• Should Quantitative Measures and Management of Rheumatoid Arthritis Include More Than Control of Inflammatory Activity?

  2021cites this paper
• TELERA—Asynchronous TELEmedicine for Patients With Rheumatoid Arthritis: Study Protocol for a Prospective, Multi-Center, Randomized Controlled Trial

  2021cites this paper
• A Proposal to Standardize Low Disease Activity Criteria in Rheumatoid Arthritis Based on the Outcome Measures in Rheumatology Minimal Disease Activity Definition

  2020cites this paper
• Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO Registry.

  2020influential citation
• Recommendations of the Romanian Society of Rheumatology regarding the management of patients with rheumatic diseases in the context of the SARS-CoV-2 pandemic

  2020cites this paper
• Treat to Target, Remission and Low Disease Activity in the Treatment of Rheumatoid Arthritis

  2020cites this paper
• Assessing Rheumatoid Arthritis Disease Activity With Patient‐Reported Outcomes Measurement Information System Measures Using Digital Technology

  2020cites this paper
• Key opinion leaders — a critical perspective

  2020cites this paper
• A comparison of physical function instruments in psoriatic arthritis: HAQ-DI vs MDHAQ vs PROMIS10 global physical health.

  2020cites this paper
• Racial disparities in pre-operative pain, function and disease activity for patients with rheumatoid arthritis undergoing Total knee or Total hip Arthroplasty: a New York based study

  2020cites this paper
• Drug Survival of Biologic Therapy in Elderly Patients With Rheumatoid Arthritis Compared With Nonelderly Patients

  2020cites this paper